CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RLAY — Relay Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,080,286
+$17,016,971 QoQ
Shares Held
1,500,817
+35.0% QoQ
Ownership
0.685%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. RLAY ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,080,286 | 1,500,817 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,063,315 | 1,111,891 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,616,498 | 1,136,702 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,801,147 | 1,111,331 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,827,659 | 1,106,260 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,789,927 | 1,064,858 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,164,524 | 1,010,807 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,333,386 | 1,035,789 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,355,469 | 821,391 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,570,903 | 912,157 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,664,721 | 877,813 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,011,510 | 714,805 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,445,268 | 672,394 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,769,436 | 653,882 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,777,378 | 654,443 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,846,291 | 618,967 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,136,857 | 545,484 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $16,299,578 | 544,590 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $16,215,432 | 528,018 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,504,992 | 428,322 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $8,158,472 | 222,970 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,713,182 | 194,191 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,631,438 | 159,563 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,603,281 | 155,043 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||